Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice
- 1 October 1984
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 26 (4) , 557-562
- https://doi.org/10.1128/aac.26.4.557
Abstract
The effects of double and triple combinations of acyclovir (ACV), adenine arabinoside (ara-A), arabinosyl hypoxanthine, or interferon on herpes simplex virus type 2 in mouse embryo fibroblasts were measured. These in vitro data were compared with results obtained in mice infected intravaginally with herpes simplex virus type 2 and treated intraperitoneally with low- and high-dose combinations of ACV, ara-A, or polyriboinosinic-polyribocytidylic acid(poly-L-lysine)carboxymethylcellulose complex [poly IC(LC)], an interferon inducer. Although all double combinations and one triple combination evoked synergistic reactions in vitro, results did not necessarily predict in vivo observations. In vivo synergy was observed when combinations of ACV and ara-A and low doses of ara-A-ACV-poly IC(LC) were used. However, toxicity was seen with full-dose nucleoside-poly IC(LC) doublets. The full-dose ACV-ara-A combination completely prevented progression beyond vaginitis, with all animals surviving. The ara-A-ACV results observed in mice, together with in vivo data of others, suggest that this combination might prove clinically useful for certain herpes simplex virus type 2 infections.This publication has 25 references indexed in Scilit:
- Treatment of First Episodes of Genital Herpes Simplex Virus Infection with Oral AcyclovirNew England Journal of Medicine, 1983
- Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in miceAntimicrobial Agents and Chemotherapy, 1982
- INTRAVENOUS ACYCLOVIR TREATMENT FOR PRIMARY GENITAL HERPESThe Lancet, 1982
- Effects of Passive Transfer and Induction of Gamma (Type II Immune) Interferon Preparations on the Metabolism of Diphenylhydantoin by Murine Cytochrome P-450Journal of Interferon Research, 1982
- Combined Antiviral Effect of Interferon and Acyclovir on Herpes Simplex Virus Types 1 and 2Antimicrobial Agents and Chemotherapy, 1981
- Antiherpesvirus Activity in Human Sera and Urines after Administration of Adenine ArabinosideJournal of Clinical Investigation, 1978
- Effect of Treatment with Exogenous Interferon, Polyriboinosinic-Polyribocytidylic Acid, or Polyriboinosinic-Polyribocytidylic Acid-Poly-L-Lysine Complex on Herpesvirus hominis Infections in MiceThe Journal of Infectious Diseases, 1978
- A Method for Testing for Synergy with Any Number of AgentsThe Journal of Infectious Diseases, 1978
- Differential Sensitivity of Herpes Simplex Virus Types 1 and 2 to Human Interferon: Antiviral Effects of Interferon plus 9- -D-ArabinofuranosyladenineThe Journal of Infectious Diseases, 1976
- A Modified Polyriboinosinic-Polyribocytidylic Acid Complex That Induces Interferon in PrimatesThe Journal of Infectious Diseases, 1975